Inventor · disambiguated record
Ailin Bai
Also filed as: BAI AILIN
28 granted patents·8 pending applications·154 citations·filing 2011–2025
97Inventor score
Top patents by PatentIndex Score
36 records- 0198US11344504B1Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2021·Granted May 31, 2022·4 cites·29 claims
- 0298US10285950B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted May 14, 2019·13 cites·20 claims
- 0398US10172808B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jan 8, 2019·19 cites·18 claims
- 0497US11403008B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2021·Granted Aug 2, 2022·3 cites·29 claims
- 0597US11071716B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2020·Granted Jul 27, 2021·3 cites·20 claims
- 0697US10646549B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2018·Granted May 12, 2020·13 cites·20 claims
- 0796US11000573B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2020·Granted May 11, 2021·3 cites·20 claims
- 0896US10406113B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Sep 10, 2019·7 cites·30 claims
- 0996US10383951B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2018·Granted Aug 20, 2019·7 cites·22 claims
- 1096US10143723B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2018·Granted Dec 4, 2018·8 cites·18 claims
- 1195US11596609B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Granted Mar 7, 2023·1 cites·20 claims
- 1295US10322090B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1395US10322091B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1494US11003366B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2019·Granted May 11, 2021·4 cites·21 claims
- 1593US10379767B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2018·Granted Aug 13, 2019·5 cites·20 claims
- 1692US10973917B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2019·Granted Apr 13, 2021·4 cites·27 claims
- 1792US10335486B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2018·Granted Jul 2, 2019·8 cites·23 claims
- 1892US9175076B2Anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·16 cites·11 claims
- 1991US11725047B2Anti-GDF-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2020·Granted Aug 15, 2023·2 cites·20 claims
- 2091US9725505B2Methods of treatment using anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·9 cites·36 claims
- 2190US11311602B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2021·Granted Apr 26, 2022·1 cites·31 claims
- 2289US11185510B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2019·Granted Nov 30, 2021·1 cites·26 claims
- 2386US12258391B2Anti-GDF-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2023·Granted Mar 25, 2025·0 cites·18 claims
- 2486US10597444B2Anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2017·Granted Mar 24, 2020·4 cites·9 claims
- 2584US11687256B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2022·Granted Jun 27, 2023·0 cites·37 claims
- 2684US8481688B2Anti-FGFR2 antibodiesWENG ZHIGANG·Filed 2011·Granted Jul 9, 2013·9 cites·7 claims
- 2783US2023041964A1Combinations of mrnas encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 2882US11571463B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2022·Granted Feb 7, 2023·0 cites·23 claims
- 2982US2024024422A1Polynucleotides encoding interleukin-12 (il12) and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 3081US2023346928A1Mrna combination therapy for the treatment of cancerMODERNATX INC·Filed 2023·Application pending·0 cites
- 3180US2023359371A1Methods of using ox40 ligand encoding polynucleotidesMODERNATX INC·Filed 2023·Application pending·0 cites
- 3276US11660341B2mRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2021·Granted May 30, 2023·0 cites·31 claims
- 3376US2025277019A1Anti-gdf-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3460US2025281583A1Composition of mrna-encoded il15 fusion proteins and methods of use thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 3553US2013288305A1Anti-fgfr2 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3649US2023081530A1Methods and compositions for treating cancer using mrna therapeuticsMODERNATX INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ailin Bai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →